Just like algae blooms in the ocean and pollen in the spring, there’s been an explosion in the past year or two of new software, related tools and lingo from the IT and mainstream/consumer side. Some ...

Non-standardized, manual, paper-based processes can slow operations and create data errors, leading to security and compliance risks, inefficient teams, high operating costs, and poor employee and ...

Microsoft's big bet on advanced AI is paying off in many ways, including propelling the company into the leadership rank of a research report on robotic process automation (RPA). The company famously ...

Forbes contributors publish independent expert analyses and insights. Ron Schmelzer covers AI and data best practices at Forbes since 2018 Around a decade ago, as AI gained renewed attention, one of ...

For businesses looking to stay competitive and resilient, automation and AI are no longer just "nice to have" — they're essential. In fact, leaders are already making necessary changes to embrace the ...

While RPA is meeting some automation needs, agencies are also looking to advanced technologies, including artificial intelligence, to solve more complicated process challenges. Alexander Slagg is a ...

Artificial intelligence and process intelligence aren’t just buzzwords — they’re strategic tools reshaping how organizations streamline operations, reduce inefficiencies and unify data across ...

Flowable recognized in the Gartner Market Guide for Business Process Automation as a Representative Vendor. Zurich, Switzerland--(Newsfile Corp. - June 25, 2025) - Flowable, a global leader in ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--ServiceNow (NYSE: NOW), the leading digital workflow company making the world work better for everyone, today announced it has signed an agreement to acquire task ...

Thirty years ago, when I studied industrial engineering, my professors drilled a fundamental principle of operational excellence into me: Never automate a bad process. Their logic was simple. By ...

Defining the steps involved in a successful technology transfer process would benefit biopharma, say the researchers behind a “generic” blueprint intended to help drug makers move more easily from ...